Company / Current Assets
10x Genomics, Inc. Current Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$684.5M
FY2025
5-year range
$584.4M / $747.6M
FY2021-FY2025
Trend
+17.1%
vs FY2024
Sector context
#95 of 165
Health Care
What the data says
At $684M, 10x Genomics, Inc.'s current assets ranks #95 of 165 in the Health Care sector. Current Assets returned to growth in FY2025 after 4 years of decline, reaching $684M.
Based on SEC 10-K filings.
$684M in FY2025 with a 5-year CAGR of -2.4%.
Improved from $596M to $684M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +2.5%
- 5-Year CAGR
- -2.4%
- 10-Year CAGR
- -
Sector benchmark
#95 of 165 in Health CareTop 58% of 165This company $684.5M Sector average $5.2B
▼
-87.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -2.4%, indicating a declining trend.
- In FY2025, current assets increased 17.1% year-over-year.
- Ranks #95 out of 165 companies in the Health Care sector.
- Peak current assets was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $684.5M | +17.1% |
| FY2024 | $584.4M | -2.0% |
| FY2023 | $596.0M | -6.1% |
| FY2022 | $635.0M | -15.1% |
| FY2021 | $747.6M | -3.5% |
| FY2020 | $774.4M | +61.0% |
| FY2019 | $480.8M | +352.6% |
| FY2018 | $106.2M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026